Health Care Industry
Industry: Email Alert RSS FeedNovartis drug diovan nears FDA approval for hypertension
Drug Store News, Nov 19, 2001 by James Frederick
Novartis received an "approvable" letter from the FDA for Diovan (valsartan) for the treatment of heart failure in patients not taking ACE inhibitors. Final approval, according to Novartis, hangs on further analysis of existing data or the submission of additional data. Diovan is a highly selective angiotensin II receptor blocker already approved for first-line treatment of hypertension in more than 80 countries, including the United States, and is one of the fastest-growing branded prescription antihypertensives.
Most RecentHealth Care Articles
An estimated 3 million patients worldwide take Diovan for high blood pressure. Heart failure, or progressive weakening of the heart muscle, is the fastest-growing cardiovascular disease in the world and has reached epidemic proportions in industrialized nations. Twenty million people worldwide have heart failure, and the condition is the most common reason why patients aged 65 or older are hospitalized.
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- 50 home remedies that work: these safe, fast, and effective fixes will relieve what ails you - Cover Story
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
- La anemia falciforme - causas y tratamiento


